Marrow Fine, LLC – Trademark Portfolio

Entity Type: 16

Marrow Fine, LLC holds 3 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 14 (Jewelry) — 3 filings in this category. The portfolio also extends into Class 35 (Advertising & Business) across 2 Nice Classification classes. Currently, 2 trademarks are registered. Notable registered marks include MARROW and MARROW FINE. The owner is based in CARDIFF BY THE SEA, CA.

2033 SAN ELIJO AVE #410

CARDIFF BY THE SEA, CA 92007

3 Total Trademarks

Add to watchlist:

No watchlists yet
Loading...
By Date
By Name
Filter by Class:

MARROW
MARROW
Registered 2018
M
M
Cancelled 2018

Trademark Classifications

Marrow Fine, LLC's trademark portfolio spans 2 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.

14
Jewelry (3 filings)

Precious metals and their alloys; jewellery, precious stones; horological instruments

35
Advertising & Business (1 filing)

Advertising; business management; business administration; office functions

Frequently Asked Questions

How many trademarks does Marrow Fine, LLC have?

Marrow Fine, LLC has 3 U.S. trademarks filed with the USPTO. Of these, 2 registered, 1 cancelled.

What trademark classes does Marrow Fine, LLC file in?

Marrow Fine, LLC files trademarks across 2 Nice Classification classes. The most active classes are Class 14 (Jewelry), Class 35 (Advertising & Business). Class 14 covers precious metals and their alloys; jewellery, precious stones; horological instruments.

What are Marrow Fine, LLC's most well-known trademarks?

Marrow Fine, LLC's registered trademark portfolio includes well-known marks such as MARROW and MARROW FINE. These are among 2 currently registered trademarks in the portfolio.

What is Marrow Fine, LLC's trademark registration success rate?

Marrow Fine, LLC has a 67% trademark registration rate, with 2 out of 3 resolved applications resulting in successful registration. Currently, 0 applications are pending review.